ArticleHaematologica2011
Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy.
Article in Haematologica, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Ascites does not accompany pleural effusion developing under dasatinib therapy in patients with CML-CP.Pleura and peritoneum · 2024Article
- Dasatinib-Induced Pleural and Pericardial Effusions.Cureus · 2021Article
- COVID-19 in Chronic-Phase Chronic Myeloid Leukemia Patients: A Single-Center Survey from TurkeyTurkish journal of haematology : official journal of Turkish Society of Haematology · 2021Article
- Malignant pericardial effusion complicated by cardiac tamponade under atezolizumab.SAGE open medical case reports · 2021Article
- Case study-based systematic review of literature on lymphoma-associated cardiac tamponade.Contemporary oncology (Poznan, Poland) · 2021Review
- Chronic myeloid leukaemia and the use of tyrosine kinase inhibitors in the days of COVID-19 pandemic.British journal of clinical pharmacology · 2020Article
- Impending Cardiac Tamponade as the Initial Manifestation of BCR-ABL Positive Chronic Myeloid Leukemia.Cureus · 2020Article
- Dasatinib-induced pulmonary arterial hypertension.British journal of clinical pharmacology · 2018Review
- Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations.Drug design, development and therapy · 2016Review
- Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia.Turkish journal of haematology : official journal of Turkish Society of Haematology · 2013Article
- Severe adverse events associated with the use of second-line BCR/ABL tyrosine kinase inhibitors: preferential occurrence in patients with comorbidities.Haematologica · 2011Article
Corrections and comments
- Comment on
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.